Correlation between mucin biology and tumor heterogeneity in lung cancer

被引:24
作者
Xu, Menglin [1 ]
Wang, Diane C. [1 ]
Wang, Xiangdong [1 ]
Zhang, Yong [1 ]
机构
[1] Fudan Univ, Shanghai Inst Clin Bioinformat, Biomed Res Ctr, Zhongshan Hosp Inst Clin Sci, Shanghai, Peoples R China
关键词
MUC; Tumor heterogeneity; Lung cancer; Diagnosis; Therapy; CELL-PROLIFERATION; EXPRESSION; RECEPTOR; GENE; GLYCOPROTEINS; CARCINOMA; GROWTH; CA125;
D O I
10.1016/j.semcdb.2016.08.027
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mucins (MUC) are a family consisting of large 0-glycoproteins whose primary functions are to protect and lubricate cell epithelial surfaces and contribute to intra- and inter-cellular signal pathways, cell proliferation, growth and apotosis. With the development of new technologies, MUCs begin to be identified as an effective marker in evaluating the tumor heterogeneity in lung cancer. MUCs' diverse expressions in subtypes of lung cancer indicate the inter-tumor heterogeneity. MUCs' mutation may also contribute to the development of intra-heterogeneity and evolution of lung cancer. Understanding MUCs' association with lung cancer heterogeneity and its molecular regulatory mechanism will benefit the development of diagnosis, therapy choice, and prognosis prediction of lung cancer. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 34 条
  • [1] Preclinical and clinical studies of recombinant poxvirus Vaccines for carcinoma therapy
    Arlen, Philip M.
    Gulley, James L.
    Madan, Ravi A.
    Hodge, James W.
    Schlom, Jeffrey
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2007, 27 (05) : 451 - 462
  • [2] MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
    Bafna, Sangeeta
    Singh, Ajay P.
    Moniaux, Nicolas
    Endy, James D.
    Meza, Jane L.
    Batra, Surinder K.
    [J]. CANCER RESEARCH, 2008, 68 (22) : 9231 - 9238
  • [3] Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
    Belisle, Jennifer A.
    Horibata, Sachi
    Jennifer, Gubbels A. A.
    Petrie, Sarah
    Kapur, Arvinder
    Andre, Sabine
    Gabius, Hans-Joachim
    Rancourt, Claudine
    Connor, Joseph
    Paulson, James C.
    Patankar, Manish S.
    [J]. MOLECULAR CANCER, 2010, 9
  • [4] MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins
    Chaturvedi, Pallavi
    Singh, Ajay P.
    Moniaux, Nicolas
    Senapati, Shantibhushan
    Chakraborty, Subhankar
    Meza, Jane L.
    Batra, Surinder K.
    [J]. MOLECULAR CANCER RESEARCH, 2007, 5 (04) : 309 - 320
  • [5] Molecular origins of cancer: Oncogenes and cancer
    Croce, Carlo M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (05) : 502 - 511
  • [6] MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition
    David, Justin M.
    Hamilton, Duane H.
    Palena, Claudia
    [J]. ONCOIMMUNOLOGY, 2016, 5 (04):
  • [7] Analysis of intratumor heterogeneity unravels lung cancer evolution
    de Bruin, Elza C.
    McGranahan, Nicholas
    Swanton, Charles
    [J]. MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (03):
  • [8] Stem cell concepts renew cancer research
    Dick, John E.
    [J]. BLOOD, 2008, 112 (13) : 4793 - 4807
  • [9] Mucin 1-mediated chemo-resistance in lung cancer cells
    Ham, S. Y.
    Kwon, T.
    Bak, Y.
    Yu, H.
    Hong, J.
    Lee, S. K.
    Yu, D-Y
    Yoon, D-Y
    [J]. ONCOGENESIS, 2016, 5 : 1 - 8
  • [10] Mucins in cancer: Protection and control of the cell surface
    Hollingsworth, MA
    Swanson, BJ
    [J]. NATURE REVIEWS CANCER, 2004, 4 (01) : 45 - 60